Miroslav Balaz

Miroslav Balaz

Auto-generated profile, based on publicly available information

Miroslav Balaz

Biomedical Research Center, Slovak Academy of Sciences, 84104 Bratislava, Slovakia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 January 2014 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
TKTimea Kurdiova
Timea Kurdiova
MBMiroslav Balaz
Miroslav Balaz
MVMarek Vician
Marek Vician
DMDenisa Maderova
Denisa Maderova
MVMiroslav Vlcek
Miroslav Vlcek
BUBarbara Ukropcová
Barbara Ukropcová

19 August 2019 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
JJJasper M. A. de Jong
Jasper M. A. de Jong
WSWenfei Sun
Wenfei Sun
NPNuno D. Pires
Nuno D. Pires
AFAndrea Frontini
Andrea Frontini
MBMiroslav Balaz
Miroslav Balaz
NPNatasa Petrovic
Natasa Petrovic

1 August 2016 in Cell Reports
Verified
Journal Article
Open access
SMSalvatore Modica
Salvatore Modica
LSLeon G. Straub
Leon G. Straub
MBMiroslav Balaz
Miroslav Balaz
WSWenfei Sun
Wenfei Sun
LVLukas Varga
Lukas Varga
Christian WolfrumChristian Wolfrum
Christian Wolfrum
While Bmp4 has a well-established role in the commitment of mesenchymal stem cells into the adipogenic lineage, its role in brown adipocyte formation and activity is not well defined. Here, we show that Bmp4 has a dual function in adipogenesis by inducing adipocyte commitment while inhibiting the acquisition of a brown phenotype during terminal differentiation. Selective brown adipose tissue overexpression of Bmp4 in mice induces a shift from a brown to a white-like adipocyte phenotype. This effect is mediated by Smad signaling and might be in part due to suppression of lipolysis, via regulation of hormone sensitive lipase expression linked to reduced Ppar activity. Given that we observed a strong correlation between BMP4 levels and adipocyte size, as well as insulin sensitivity in humans, we propose that Bmp4 is an important factor in the context of obesity and type 2 diabetes.

1 October 2018 in Cell Reports
Verified
Journal Article
Open access
APAliki Perdikari
Aliki Perdikari
GLGermán Gastón Leparc
Germán Gastón Leparc
MBMiroslav Balaz
Miroslav Balaz
NPNuno D. Pires
Nuno D. Pires
MLMartin E. Lidell
Martin E. Lidell
Christian WolfrumChristian Wolfrum
Christian Wolfrum
Recruitment and activation of thermogenic adipocytes have received increasing attention as a strategy to improve systemic metabolic control. The analysis of brown and brite adipocytes is complicated by the complexity of adipose tissue biopsies. Here, we provide an in-depth analysis of pure brown, brite, and white adipocyte transcriptomes. By combining mouse and human transcriptome data, we identify a gene signature that can classify brown and white adipocytes in mice and men. Using a machine-learning-based cell deconvolution approach, we develop an algorithm proficient in calculating the brown adipocyte content in complex human and mouse biopsies. Applying this algorithm, we can show in a human weight loss study that brown adipose tissue (BAT) content is associated with energy expenditure and the propensity to lose weight. This online available tool can be used for in-depth characterization of complex adipose tissue samples and may support the development of therapeutic strategies to increase energy expenditure in humans.

9 July 2018 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
WSWenfei Sun
Wenfei Sun
HDHua Dong
Hua Dong
ABAnton S. Becker
Anton S. Becker
DDDianne H. Dapito
Dianne H. Dapito
SMSalvatore Modica
Salvatore Modica
Christian WolfrumChristian Wolfrum
Christian Wolfrum

16 January 2020 in JCI Insight
Verified
Journal Article
Closed access
PDF file
MCMathias Cardner
Mathias Cardner
MYMustafa Yalcinkaya
Mustafa Yalcinkaya
SGSandra Goetze
Sandra Goetze
ELEdlira Luca
Edlira Luca
MBMiroslav Balaz
Miroslav Balaz
Arnold Von EckardsteinArnold Von Eckardstein
Arnold Von Eckardstein
High-density lipoproteins (HDL) contain hundreds of lipid species and proteins and exert many potentially vasoprotective and antidiabetogenic activities on cells. To resolve structure-function-disease relationships of HDL, we characterized HDL of 51 healthy subjects and 98 patients with diabetes (T2DM), coronary heart disease (CHD), or both for protein and lipid composition, as well as functionality in 5 cell types. The integration of 40 clinical characteristics, 34 nuclear magnetic resonance (NMR) features, 182 proteins, 227 lipid species, and 12 functional read-outs by high-dimensional statistical modeling revealed, first, that CHD and T2DM are associated with different changes of HDL in size distribution, protein and lipid composition, and function. Second, different cellular functions of HDL are weakly correlated with each other and determined by different structural components. Cholesterol efflux capacity (CEC) was no proxy of other functions. Third, 3 potentially novel determinants of HDL function were identified and validated by the use of artificially reconstituted HDL, namely the sphingadienine-based sphingomyelin SM 42:3 and glycosylphosphatidylinositol-phospholipase D1 for the ability of HDL to inhibit starvation-induced apoptosis of human aortic endothelial cells and apolipoprotein F for the ability of HDL to promote maximal respiration of brown adipocytes.